» Articles » PMID: 7543676

Signaling Through the Interleukin 2 Receptor Beta Chain Activates a STAT-5-like DNA-binding Activity

Overview
Specialty Science
Date 1995 Aug 1
PMID 7543676
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

To explore the possible involvement of STAT factors ("signal transducers and activators of transcription") in the interleukin 2 receptor (IL-2R) signaling cascade, murine HT-2 cells expressing chimeric receptors composed of the extracellular domain of the erythropoietin receptor fused to the cytoplasmic domains of the IL-2R beta or -gamma c chains were prepared. Erythropoietin or IL-2 activation of these cells resulted in rapid nuclear expression of a DNA-binding activity that reacted with select STAT response elements. Based on reactivity with specific anti-STAT antibodies, this DNA-binding activity was identified as a murine homologue of STAT-5. Induction of nuclear expression of this STAT-5-like factor was blocked by the addition of herbimycin A, a tyrosine kinase inhibitor, but not by rapamycin, an immunophilin-binding antagonist of IL-2-induced proliferation. The IL-2R beta chain appeared critical for IL-2-induced activation of STAT-5, since a mutant beta chain lacking all cytoplasmic tyrosine residues was incapable of inducing this DNA binding. In contrast, a gamma c mutant lacking all of its cytoplasmic tyrosine residues proved fully competent for the induction of STAT-5. Physical binding of STAT-5 to functionally important tyrosine residues within IL-2R beta was supported by the finding that phosphorylated, but not nonphosphorylated, peptides corresponding to sequences spanning Y392 and Y510 of the IL-2R beta tail specifically inhibited STAT-5 DNA binding.

Citing Articles

Engineered chimeric receptors for dissecting interferon signaling.

Lin A, Mesev E, Toettcher J, Ploss A J Virol. 2024; 98(10):e0168023.

PMID: 39291974 PMC: 11495025. DOI: 10.1128/jvi.01680-23.


IL-17 integrates multiple self-reinforcing, feed-forward mechanisms through the RNA binding protein Arid5a.

Amatya N, Childs E, Cruz J, Aggor F, Garg A, Berman A Sci Signal. 2018; 11(551).

PMID: 30301788 PMC: 6188668. DOI: 10.1126/scisignal.aat4617.


Common gamma chain cytokines in combinatorial immune strategies against cancer.

Pulliam S, Uzhachenko R, Adunyah S, Shanker A Immunol Lett. 2015; 169:61-72.

PMID: 26597610 PMC: 4710466. DOI: 10.1016/j.imlet.2015.11.007.


Nitric oxide enhances Th9 cell differentiation and airway inflammation.

Niedbala W, Besnard A, Nascimento D, Donate P, Sonego F, Yip E Nat Commun. 2014; 5:4575.

PMID: 25099390 PMC: 4131005. DOI: 10.1038/ncomms5575.


Differential regulation of the IL-17 receptor by gammac cytokines: inhibitory signaling by the phosphatidylinositol 3-kinase pathway.

Lindemann M, Hu Z, Benczik M, Liu K, Gaffen S J Biol Chem. 2008; 283(20):14100-8.

PMID: 18348982 PMC: 2376247. DOI: 10.1074/jbc.M801357200.


References
1.
Kuo C, Chung J, Fiorentino D, Flanagan W, Blenis J, Crabtree G . Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature. 1992; 358(6381):70-3. DOI: 10.1038/358070a0. View

2.
Greenlund A, Farrar M, Viviano B, Schreiber R . Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J. 1994; 13(7):1591-600. PMC: 394989. DOI: 10.1002/j.1460-2075.1994.tb06422.x. View

3.
Smith K . Interleukin-2. Curr Opin Immunol. 1992; 4(3):271-6. DOI: 10.1016/0952-7915(92)90076-q. View

4.
Lamb P, Kessler L, Suto C, Levy D, Seidel H, Stein R . Rapid activation of proteins that interact with the interferon gamma activation site in response to multiple cytokines. Blood. 1994; 83(8):2063-71. View

5.
Grabstein K, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V . Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science. 1994; 264(5161):965-8. DOI: 10.1126/science.8178155. View